These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26402469)

  • 1. Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia.
    Olivieri J; Mancini G; Goteri G; Scortechini I; Giantomassi F; Chiarucci M; Leoni P; Olivieri A
    Leuk Lymphoma; 2016; 57(4):965-8. PubMed ID: 26402469
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes of allogeneic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria with or without aplastic anemia.
    Lee SE; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Lee JW
    Eur J Haematol; 2017 Oct; 99(4):336-343. PubMed ID: 28675769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotransplantation of haploidentical hematopoietic stem cells and allogeneic bone marrow-derived mesenchymal stromal cells as a first-line treatment in very severe aplastic anemia patients with refractory infections.
    Yue C; Ding Y; Gao Y; Li L; Pang Y; Liu Z; Zhang H; Xiao Y; Jiang Z; Xiao H
    Eur J Haematol; 2018 Jun; 100(6):624-629. PubMed ID: 29532539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progresses in studies on allogeneic hematopoietic stem cell transplantation in children with acquired severe aplastic anemia].
    Liu TF; Zhu XF
    Zhonghua Er Ke Za Zhi; 2013 May; 51(5):345-8. PubMed ID: 23941840
    [No Abstract]   [Full Text] [Related]  

  • 5. Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study.
    Xu LP; Wang SQ; Wu DP; Wang JM; Gao SJ; Jiang M; Wang CB; Zhang X; Liu QF; Xia LH; Wang X; Huang XJ
    Br J Haematol; 2016 Oct; 175(2):265-274. PubMed ID: 27352174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conditioning regimen of allogeneic hematopoietic stem cell transplantation for aplastic anemia in Japan].
    Mori T
    Rinsho Ketsueki; 2011 Aug; 52(8):674-8. PubMed ID: 21897074
    [No Abstract]   [Full Text] [Related]  

  • 7. Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia.
    Al-Zahrani H; Nassar A; Al-Mohareb F; Al-Sharif F; Mohamed S; Al-Anazi K; Patel M; Rasheed W; Saleh AJ; Bakr M; Ahmed S; Ibrahim K; Hussain F; Elkum N; Elhassan T; Nurgat Z; Chaudhri N; Aljurf M
    Biol Blood Marrow Transplant; 2011 May; 17(5):717-22. PubMed ID: 20736079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
    Okuda S; Terasako K; Oshima K; Sato M; Nakasone H; Kako S; Yamazaki R; Tanaka Y; Tanihara A; Higuchi T; Nishida J; Kanda Y
    Am J Hematol; 2009 Mar; 84(3):167-9. PubMed ID: 19195036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic stem cell transplantation for aplastic anemia.
    Armand P; Antin JH
    Biol Blood Marrow Transplant; 2007 May; 13(5):505-16. PubMed ID: 17448909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of allogeneic stem cell transplantation for patients transformed to myelodysplastic syndrome or leukemia from severe aplastic anemia: a report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
    Hussein AA; Halkes CM; Socié G; Tichelli A; von dem Borne PA; Schaap MN; Foa R; Ganser A; Dufour C; Bacigalupo A; Locasciulli A; Aljurf M; Peters C; Robin M; van Biezen AA; Volin L; De Witte T; Marsh J; Passweg JR; Kröger N;
    Biol Blood Marrow Transplant; 2014 Sep; 20(9):1448-50. PubMed ID: 24910382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia.
    Onishi Y; Mori T; Kako S; Koh H; Uchida N; Kondo T; Kobayashi T; Yabe H; Miyamoto T; Kato K; Suzuki R; Nakao S; Yamazaki H;
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2137-2142. PubMed ID: 28844947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party.
    Devillier R; Dalle JH; Kulasekararaj A; D'aveni M; Clément L; Chybicka A; Vigouroux S; Chevallier P; Koh M; Bertrand Y; Michallet M; Zecca M; Yakoub-Agha I; Cahn JY; Ljungman P; Bernard M; Loiseau P; Dubois V; Maury S; Socié G; Dufour C; Peffault de Latour R
    Haematologica; 2016 Jul; 101(7):884-90. PubMed ID: 27056924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic Hematopoietic Stem Cell Transplant for Severe Aplastic Anemia: Current State and Future Directions.
    Sun Q; Wu B; Zhu Z; Sun C; Xu J; Long H; Huang Y; Xu J; Song C
    Curr Stem Cell Res Ther; 2018; 13(5):350-355. PubMed ID: 28245775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic peripheral blood stem cell transplantation in aplastic anemia.
    Damodar S; Murthy S
    Indian Pediatr; 2006 Jan; 43(1):82-3. PubMed ID: 16465020
    [No Abstract]   [Full Text] [Related]  

  • 15. [Allogeneic stem cell transplantation for severe aplastic anemia and myelodysplasia].
    Okamoto S
    Nihon Rinsho; 2008 Mar; 66(3):575-83. PubMed ID: 18326329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia.
    Kudo K; Muramatsu H; Yoshida N; Kobayashi R; Yabe H; Tabuchi K; Kato K; Koh K; Takahashi Y; Hashii Y; Kawano Y; Inoue M; Cho Y; Sakamaki H; Kawa K; Kato K; Suzuki R; Kojima S
    Bone Marrow Transplant; 2015 Oct; 50(10):1312-5. PubMed ID: 26121106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditioning with purine analogs leads to good engraftment rates of immunodepleted grafts for aplastic anemia.
    Novitzky N; Thomas V; du Toit C
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):584-8. PubMed ID: 23270985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T Cells.
    Grimaldi F; Potter V; Perez-Abellan P; Veluchamy JP; Atif M; Grain R; Sen M; Best S; Lea N; Rice C; Pagliuca A; Mufti GJ; Marsh JCW; Barber LD
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):293-299. PubMed ID: 27816648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.
    Rzepecki P; Sarosiek T; Szczylik C
    Jpn J Clin Oncol; 2006 Jan; 36(1):46-9. PubMed ID: 16423840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.